Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¶¸ð»óÇÇ¾È ¼¼Æ÷ÁÖ¿¡¼­ Transforming Growth Factor-B1ÀÇ ¼¼Æ÷ ¼ºÀå ¹× c-myc¾ÏÀ¯ÀüÀÚ ¹ßÇö ¾ïÁ¦È¿°ú Inhibitory Effect of Transforming Growth Factor-B1, on Celluiar Proliferation and c-myc Expression in Chorlocarcinoma Cell Line

´ëÇѾÏÇÐȸÁö 1995³â 27±Ç 6È£ p.961 ~ 967
¼Ò¼Ó »ó¼¼Á¤º¸
±è»çÁø ±èÁø¿ì/³ªÁ¾±¸/À̱ͼ¼¶ó/¼Û½Â±Ô/³²±Ã¼ºÀº

Abstract


Modulation of cellular proliferation and c-myc oncogene expression after treatment of human choriocarcinoma cell line(BeWo) with transorming growth factor-¥â(TGF-¥â1) have been investigated by MTT [3-4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium
bromide] assay and northern blotting analysis. TGF-¥â1 inhibited BeWo cell growth in a dose dependent manner at concentrations of 0.001~10ng/ml. When BeWo cells were exposed to 10ng/ml of TGF-¥â1, c-myc was repressed after 4hr and completely
abolished
at 24hr of stimulation. These results show that TGF-¥â1 may play an antiproliferative effect on BeWo cell growth via c-myc gene product. In vitro analysis of cellular and molecular alterations in BeWo cells in this study may aid in elucidating
the
mechanism of action of TGF-¥â1 on human choriocarcinoma tissues in vivo

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS